Nanocrine
Frederick, US · 2 known investors
Find your way into Nanocrine
59 people in our graph share verified history with the Nanocrine team — schools, employers, funds. One of them is your warm intro.
Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.
Founders & leadership



Investors · 2
Competitors · 3
by search overlapCompanies competing with Nanocrine for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2020 | $248.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Nanocrine do?
- Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.
- Who founded Nanocrine?
- Nanocrine was founded by Steve Turner, Jim Bailey.
- Who are Nanocrine's investors?
- Nanocrine's investors include Maryland TEDCO, TEDCO.
- Where is Nanocrine headquartered?
- Nanocrine is headquartered in Frederick, US.



